SlideShare a Scribd company logo
Dr. Mukesh Kumar Shukla
Senior Resident
Department of Medicine
Hind Institute Of Medical Sciences
Peripheral neuropathy.ug
Peripheral neuropathy.ug
Peripheral neuropathy.ug
Peripheral neuropathy.ug
Peripheral neuropathy.ug
Peripheral neuropathy.ug
Peripheral neuropathy.ug
 Neuropathy indicates disorder or malfunction of the
nerves.
 It refers to involvement of peripheral nervous system .
 It is a common neurological disorder.
1. Cranial nerves (with the
exception of the second)
2. Spinal nerve roots
3. Dorsal root ganglia
4. Peripheral nerve trunks
and their terminal
branches
5. Peripheral autonomic
nervous system
 The overall prevalence is 2.4%;
 It increases to 8% in individuals aged above
55 years.
 Diabetes mellitus is the most common cause
worldwide.
1. Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J
Neurol Neurosurg Psychiatry.1997;62:310–8.
2. Medicine and Rehabilitation. Neurology 2009;72(2):185Y192.
1. Is this a peripheral neuropathy?
2. What is its distribution?
3. Which fibers are affected?
4. What is the anatomic pattern?
5. What is the time course?
6. What is the likely etiology?
7. Is there evidence of hereditary neuropathy ?
 The initial step is to confirm whether the signs and
symptoms are related to peripheral nerve dysfunction.
 Patients may present with positive and/or negative
symptoms.
 The initial symptoms are often intermittent and
examination can be normal.
 In most situations, sensory symptoms precede motor
symptoms.
 Positive sensory symptoms
◦ burning,
◦ lancinating pain,
◦ tingling,
◦ pins and needles
◦ walking on cotton wool,
 Negative sensory symptoms
◦ numbness,
◦ difficulty differentiating hot from cold
◦ worsening of balance in the dark
 Negative motor symptoms
◦ Wasting
◦ Weakness (difficulty in turning keys in locks, unfasten button, opening
bottles and jars, tripping on rugs or uneven ground.)
• Positive motor symptoms
 Cramps
 Twitching
• In the early stage, weakness is distal.
• Early proximal weakness
 inflammatory neuropathy
 porphyric neuropathy.
 Autonomic symptoms
◦ lightheadedness associated with orthostasis,
◦ impotence,
◦ sphincter disturbance,
◦ early satiety or bloating
◦ diarrhea,
◦ constipation,
◦ abnormality of sweating
(hyperhydrosis/anhydrosis)
 Patient should be asked regarding location at first involvement
and asymmetry at the onset
 On the basis of distribution, neuropathies can be categorized
into
1. Mononeuropathy,
2. Mononeuropathy multiplex
3. Polyneuropathy
 It refers to single peripheral nerve involvement
 Usually occur due to trauma, compression or entrapment.
 The common entrapment neuropathies are
◦ carpal tunnel syndrome,
◦ ulnar nerve entrapment at the elbow
◦ peroneal nerve entrapment at the head of the
fibula.
Peripheral neuropathy.ug
 Refers to the involvement of multiple, separate
noncontiguous peripheral nerves either simultaneously or
sequentially.
 Sometimes, mononeuropathy may aggregate resembling
polyneuropathy.
 Occurs most commonly due to
◦ leprosy and
◦ systemic vasculitis (polyarteritis nodosa, Churg-
Strauss syndrome, rheumatoid arthritis, Sjogren's
syndrome)
 Most common variety of neuropathy.
 The nerve fibers are affected in a length-
dependent pattern.
 A majority of these cases occur due to
◦metabolic,
◦toxic or
◦systemic disorders.
 In a polyneuropathy, manifestations can be classified as
◦ Small-fiber sensory,
◦ Large-fiber sensory,
◦ Motor
◦ Autonomic
Peripheral neuropathy.ug
 Clinical evaluation is often helpful in categorizing a
neuropathy as
◦ axonal,
◦ demyelinating,
◦ neuronal [dorsal root ganglion (DRG)]
 Most axonal neuropathies follow length-dependent pattern
with sensory symptoms & signs predominating over
motor; distal reflexes are absent.
Most demyelinating neuropathies affect
motor & sensory fibers (large fiber >
small fiber) equally & areflexia or
hyporeflexia is more generalized.
DRG lesions involve purely sensory
fibers in a non-length-dependent fashion;
sensory ataxia & generalized loss of
reflexes are usually found.
Peripheral neuropathy.ug
 The is important in categorizing neuropathy.
◦ Acute (<4 weeks),
◦ Sub-acute (4–8 weeks)
◦ Chronic (>8 weeks).
Peripheral neuropathy.ug
 The standard history, physical examination and well planned
battery of investigations serve as general framework to
determine the etiology of neuropathy
 Despite of this, in 25 to 30% of the patients in tertiary referral
centers evaluated by experts, the etiology cannot be
established.
 History should include questions regarding
◦ occupation (possibility of toxic exposures to solvents, glues,
fertilizers)
◦ dietary habits (e.g. strict vegan diet)
◦ excessive alcohol intake,
◦ smoking (para-neoplastic disease).
◦ sexual history (HIV, hepatitis C)
 A childhood history of ‘‘clumsiness’’ or poor athletic
performance suggests a hereditary cause
 History should focus on illnesses associated with neuropathy,
such as
◦ endocrinopathy (diabetes mellitus, hypothyroidism),
◦ renal insufficiency,
◦ hepatic dysfunction,
◦ connective tissue disorders,
◦ Cancer
 Surgical history should address
◦ bariatric surgery,
◦ multiple orthopedic procedures,
◦ surgeries for ‘‘entrapped nerves.’’
 Skin and mucous membranes may demonstrate
◦ Maculo-anesthetic patches with thickened nerves (Leprosy)
◦ purpura, livedo reticularis (vasculitis )
◦ oral ulcers ( HIV),
◦ salivary gland swelling, dry eyes or mouth (sarcoidosis, Sjogren
syndrome),
◦ gum ‘‘lead lines’’ (lead exposure).
 Nerve enlargement can be seen in
◦ Leprosy
◦ Heriditary motor and sensory neuropathy
◦ Refsum’s disease
◦ Amyloidosis
 Easy locations to palpate nerves are
◦ the greater auricular nerve
◦ the ulnar nerve
◦ the superficial radial nerve
◦ the common peroneal nerve
 Skeletal deformities hammer toes, pes cavus, and
kyphoscoliosis are suggestive of an inherited
polyneuropathy.
 Feet should be specifically examined for signs of trauma
as an insensate foot could be an early indicator of an
impending Charcot foot deformity.
 Anosmia (Refsum's disease, vitamin B12 deficiency)
 Optic atrophy (inherited neuropathies,vit B12 deficiency)
 External ophthalmoplegia (Miller Fisher syndrome,
Botulism,Diabetes)
 Trigeminal sensory loss (Sjogren's syndrome)
 Facial weakness (GB syndrome)
 Muscle power testing in context of nerve & root distribution
is crucial.
 It should assess muscle bulk, tone, and strength.
 Because most neuropathies cause distal weakness, the
intrinsic foot muscles may be affected first, resulting in
clawed feet and hammer toes.
 Approached with nerve anatomy & disease
type in mind.
 Monofilament probes can grade severity of
loss.
 Test modalities that sub-serve
◦ large fibers (vibration, joint position and
Rhomberg’s test)
◦ small fiber (pinprick, pain and temperature)
 Ankle hyporeflexia or areflexia is common in large fiber
neuropathy,
 Ankle reflexes are typically preserved with small fiber
neuropathy (SFN). .
 Distal reflex loss are characteristic of length-dependent
axonopathies.
Peripheral neuropathy.ug
 Routine blood investigations:
◦ Blood count
◦ ESR
◦ Blood sugar
◦ Liver and renal function tests
◦ Serum vitamin B12
◦ Thyroid function test
 Blood investigations depending upon suspected etiology
◦ Vasculitis profile
◦ HIV ELISA
◦ Heavy metal screening
 Electrodiagnostic studies
◦ EDx studies may be repeated to
monitor disease progression.
◦ These tests are the standard for large
fiber polyneuropathy diagnosis and
are normal in purely SFN.
 Bedside autonomic tests:
◦ Blood pressure response to standing (Normal fall: <20/10 mmHg),
◦ HR variation with respiration (normal: ≥15 beats/m, I:E ratio 1.2),
 Cerebrospinal fluid (CSF)
◦ useful in CIDP, AIDP and chronic immune-mediated axonal
neuropathies where CSF protein are elevated
Genetic testing – For hereditary causes
 Rarely performed now a days
 Primary indication is amyloid neuropathy and
vasculitis
 Should only be performed when NCS is
abnormal
 Sural nerve is the most commonly biopsied
nerve as it is pure sensory nerve
 Sometimes used to diagnose small fibre
neuropathy
 Used to measure density of small
unmyelinated fibre
 Density of these fibres are reduced in whom
nerve biopsy and NCS are abnormal
 Other tests
◦ chest x-ray or CT-thorax for sarcoidosis;
◦ PET scan or CT of chest, abdomen, and pelvis for malignancy;
◦ Skeletal survey and bone marrow biopsy for lymphoproliferative
diseases
◦ Salivary gland biopsy for Sjogren syndrome;
◦ Endoscopy and duodenal biopsy for celiac disease
◦ MRI may document nerve root enhancement in CIDP, show nerve
root clumping in arachnoiditis, or reveal nerve enlargement in
tumors.
Peripheral neuropathy.ug
Diabetes1 2
Paraproteinaemia2 3
Alcohol misuse1
Renal failure1
Vitamin B-12 deficiency1
HIV infection1
Chronic idiopathic 4
axonal neuropathy
Prevalence
11-41% (depending on
duration, type,and
control)
9-10%
7%
4%
3.6%
16% (depending on the
population studied,
usually much lower)
10-40% of different
hospital series
BMJ 2010:341:c6100
SJOGREN’S SYNDROME
VIT B12 NEUROPATHY
CISPLATIN
PYRIDOXINE NEUROTOXICITY
FRIEDEREICH’S ATAXIA
Heriditary sensory neuropathy
Lepromatous leprosy
Diabetes mellitus
Amyloidosis(early familial&primary)
Tangier disease
Fabry’s disease-pain predomonates
Dysautonomia-riley-day syndrome
HIV & antiretroviral therapy neuropathy
Global sensory loss
Carcinomatous sensory neuropathy
Hereditary sensory neuropathy
Diabetic sensory neuropathy
Vacor intoxication
Xanthomatous neuropathy of primary biliary
cirrhosis
Immune neuropathies
Heriditary motor sensory neuropathies
Acute intermittent porphyria
Diphtheritic neuropathy
Lead neuropathy
Brachial neuritis
Diabetic lumbosacralplexus neuropathy
Acute-pandysautonomia
-botulism
-porphyria
-GBS
-Amiodarone
-vincristine
Chronic-amyloid,diabetes,sjogren’s,HSN
1&3,chagas,paraneoplastic
RECURRENT POLYNEUROPATHY
Relapsing CIDP
Porphyria
Refsum’s disease
HNPP
GBS
Beriberi
Toxic neuropathy
◦ Guillain-Barré syndrome
◦ Chronic inflammatory demyelinating
polyradiculoneuropathy
◦ Diabetes mellitus
◦ Porphyria
◦ Osteosclerotic myeloma
◦ Waldenstrom's macroglobulinemia
◦ Monoclonal gammopathy of undetermined significance
◦ Acute arsenic polyneuropathy
◦ Lymphoma
◦ Diphtheria
◦ HIV/AIDS
◦ Lyme disease
◦ Hypothyroidism
◦ Vincristine (Oncovin, Vincosar PFS) toxicity
 Treatment of the underlying disorder
◦ Glycemic control for diabetic neuropathy,
◦ Vitamin replacement for B12 deficiency,
◦ Immunosuppression for vasculitis,
◦ Surgery for entrapment neuropathy,
◦ Enzyme replacement for genetic diseases
 Pain management
 Supportive care to protect and rehabilitate damaged tissue.
 First line-Lidoderm 5% patch,TCA,Gabapentin
Pregabalin,Duloxetine
 Second line-
Carbamazepine,Phenytoin,Venlafaxine,Trama
dol
 Third line-Mexiletene
 Others-EMLA Cream,Capsaicin
Peripheral neuropathy.ug
case of neuropathy
|
Motor Sensory Autonomic Mixed
|
Focal Multifocal Generalized
|
Proximal or Distal Symmetric or asymmetr
|
UMN features present or not
|
Acute Subacute Chronic
|
Narrow down etiology and go for Edx studies
Peripheral neuropathy.ug
Peripheral neuropathy.ug

More Related Content

PPTX
Approach to PERIPHERAL NEUROPATHY
PPTX
Peripheral neuropathy
PPT
Diabetic POLYNEUROPATHY
PPTX
Consciousness, ras and approach to coma
PPTX
Neuromyelitis optica spectrum disorders
PPTX
Approach to peripheral neuropathy
PPTX
Toxic neuropathy
PPTX
Endocrine hypertension
Approach to PERIPHERAL NEUROPATHY
Peripheral neuropathy
Diabetic POLYNEUROPATHY
Consciousness, ras and approach to coma
Neuromyelitis optica spectrum disorders
Approach to peripheral neuropathy
Toxic neuropathy
Endocrine hypertension

What's hot (20)

PPTX
1. diabetic neuropathy
PPTX
Autoimmune encephalitis current concepts
PPTX
Hereditary neuropathies
PPTX
Takayasu arteritis
PPTX
Pediatric epilepsy syndromes
PPTX
Autoimmune encephalitis
PPT
Paraneoplastic syndromes CNS manifestations
PDF
Topic scleroderma and kidney Chaken Maniyan
PPTX
Approach to a patient with peripheral neuropathy
PPTX
Disorders of the Neuromuscular junction
PPTX
Myasthenia gravis management guideline
PPTX
CIDP guidelines
PPTX
Vasculitis and nervous system
PPTX
Recurrent meningitis
PDF
Stroke in Young
PPTX
Approach to peripheral neuropathy
PPTX
Posterior circulation stroke
PPT
Myotonic muscle disorders
PPTX
Polyarteritis nodosa
PPTX
Nmo ppt
 
1. diabetic neuropathy
Autoimmune encephalitis current concepts
Hereditary neuropathies
Takayasu arteritis
Pediatric epilepsy syndromes
Autoimmune encephalitis
Paraneoplastic syndromes CNS manifestations
Topic scleroderma and kidney Chaken Maniyan
Approach to a patient with peripheral neuropathy
Disorders of the Neuromuscular junction
Myasthenia gravis management guideline
CIDP guidelines
Vasculitis and nervous system
Recurrent meningitis
Stroke in Young
Approach to peripheral neuropathy
Posterior circulation stroke
Myotonic muscle disorders
Polyarteritis nodosa
Nmo ppt
 
Ad

Similar to Peripheral neuropathy.ug (20)

PPT
Peripheral neuropathy
PDF
Approach to Peripheral neuropathy
PPTX
Peripheral neuropathy
PPTX
PN by Sam.pptx for medical students and residents
PPTX
Peripheral neuropathies - Sami Yvbnnnn2.pptx
PPTX
Peripheral neuropathy Anatomy, Physiology and Diseases
PPTX
Peripheral neuropathy
PPTX
Approach to Peripheral Neuropathy
PPTX
Approach to Peripheral Neuropathy
PPTX
Peripheral neuropathy
PPTX
Neuropathy
PPTX
Neuropathy
PPTX
Neuropathy
PPTX
Peripheral Neuropathy
PPTX
Peripheral Neuropathies.pptx
PPT
Peripheral Neuropathy an overview
PPT
Neuropathy ..paras
PPTX
Sensory manifestations of systemic diseases
PPT
Peripheral Neuropathy
Peripheral neuropathy
Approach to Peripheral neuropathy
Peripheral neuropathy
PN by Sam.pptx for medical students and residents
Peripheral neuropathies - Sami Yvbnnnn2.pptx
Peripheral neuropathy Anatomy, Physiology and Diseases
Peripheral neuropathy
Approach to Peripheral Neuropathy
Approach to Peripheral Neuropathy
Peripheral neuropathy
Neuropathy
Neuropathy
Neuropathy
Peripheral Neuropathy
Peripheral Neuropathies.pptx
Peripheral Neuropathy an overview
Neuropathy ..paras
Sensory manifestations of systemic diseases
Peripheral Neuropathy
Ad

Recently uploaded (20)

PPTX
20th Century Theater, Methods, History.pptx
PDF
advance database management system book.pdf
PDF
A GUIDE TO GENETICS FOR UNDERGRADUATE MEDICAL STUDENTS
PDF
HVAC Specification 2024 according to central public works department
PPTX
TNA_Presentation-1-Final(SAVE)) (1).pptx
PPTX
Introduction to Building Materials
PPTX
Share_Module_2_Power_conflict_and_negotiation.pptx
PPTX
History, Philosophy and sociology of education (1).pptx
PDF
Trump Administration's workforce development strategy
PDF
Weekly quiz Compilation Jan -July 25.pdf
PDF
LDMMIA Reiki Yoga Finals Review Spring Summer
PDF
احياء السادس العلمي - الفصل الثالث (التكاثر) منهج متميزين/كلية بغداد/موهوبين
PDF
FOISHS ANNUAL IMPLEMENTATION PLAN 2025.pdf
PDF
1_English_Language_Set_2.pdf probationary
PDF
AI-driven educational solutions for real-life interventions in the Philippine...
PDF
ChatGPT for Dummies - Pam Baker Ccesa007.pdf
PDF
OBE - B.A.(HON'S) IN INTERIOR ARCHITECTURE -Ar.MOHIUDDIN.pdf
PDF
Hazard Identification & Risk Assessment .pdf
PPTX
Chinmaya Tiranga Azadi Quiz (Class 7-8 )
PPTX
CHAPTER IV. MAN AND BIOSPHERE AND ITS TOTALITY.pptx
20th Century Theater, Methods, History.pptx
advance database management system book.pdf
A GUIDE TO GENETICS FOR UNDERGRADUATE MEDICAL STUDENTS
HVAC Specification 2024 according to central public works department
TNA_Presentation-1-Final(SAVE)) (1).pptx
Introduction to Building Materials
Share_Module_2_Power_conflict_and_negotiation.pptx
History, Philosophy and sociology of education (1).pptx
Trump Administration's workforce development strategy
Weekly quiz Compilation Jan -July 25.pdf
LDMMIA Reiki Yoga Finals Review Spring Summer
احياء السادس العلمي - الفصل الثالث (التكاثر) منهج متميزين/كلية بغداد/موهوبين
FOISHS ANNUAL IMPLEMENTATION PLAN 2025.pdf
1_English_Language_Set_2.pdf probationary
AI-driven educational solutions for real-life interventions in the Philippine...
ChatGPT for Dummies - Pam Baker Ccesa007.pdf
OBE - B.A.(HON'S) IN INTERIOR ARCHITECTURE -Ar.MOHIUDDIN.pdf
Hazard Identification & Risk Assessment .pdf
Chinmaya Tiranga Azadi Quiz (Class 7-8 )
CHAPTER IV. MAN AND BIOSPHERE AND ITS TOTALITY.pptx

Peripheral neuropathy.ug

  • 1. Dr. Mukesh Kumar Shukla Senior Resident Department of Medicine Hind Institute Of Medical Sciences
  • 9.  Neuropathy indicates disorder or malfunction of the nerves.  It refers to involvement of peripheral nervous system .  It is a common neurological disorder.
  • 10. 1. Cranial nerves (with the exception of the second) 2. Spinal nerve roots 3. Dorsal root ganglia 4. Peripheral nerve trunks and their terminal branches 5. Peripheral autonomic nervous system
  • 11.  The overall prevalence is 2.4%;  It increases to 8% in individuals aged above 55 years.  Diabetes mellitus is the most common cause worldwide. 1. Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry.1997;62:310–8. 2. Medicine and Rehabilitation. Neurology 2009;72(2):185Y192.
  • 12. 1. Is this a peripheral neuropathy? 2. What is its distribution? 3. Which fibers are affected? 4. What is the anatomic pattern? 5. What is the time course? 6. What is the likely etiology? 7. Is there evidence of hereditary neuropathy ?
  • 13.  The initial step is to confirm whether the signs and symptoms are related to peripheral nerve dysfunction.
  • 14.  Patients may present with positive and/or negative symptoms.  The initial symptoms are often intermittent and examination can be normal.  In most situations, sensory symptoms precede motor symptoms.
  • 15.  Positive sensory symptoms ◦ burning, ◦ lancinating pain, ◦ tingling, ◦ pins and needles ◦ walking on cotton wool,  Negative sensory symptoms ◦ numbness, ◦ difficulty differentiating hot from cold ◦ worsening of balance in the dark
  • 16.  Negative motor symptoms ◦ Wasting ◦ Weakness (difficulty in turning keys in locks, unfasten button, opening bottles and jars, tripping on rugs or uneven ground.) • Positive motor symptoms  Cramps  Twitching • In the early stage, weakness is distal. • Early proximal weakness  inflammatory neuropathy  porphyric neuropathy.
  • 17.  Autonomic symptoms ◦ lightheadedness associated with orthostasis, ◦ impotence, ◦ sphincter disturbance, ◦ early satiety or bloating ◦ diarrhea, ◦ constipation, ◦ abnormality of sweating (hyperhydrosis/anhydrosis)
  • 18.  Patient should be asked regarding location at first involvement and asymmetry at the onset  On the basis of distribution, neuropathies can be categorized into 1. Mononeuropathy, 2. Mononeuropathy multiplex 3. Polyneuropathy
  • 19.  It refers to single peripheral nerve involvement  Usually occur due to trauma, compression or entrapment.  The common entrapment neuropathies are ◦ carpal tunnel syndrome, ◦ ulnar nerve entrapment at the elbow ◦ peroneal nerve entrapment at the head of the fibula.
  • 21.  Refers to the involvement of multiple, separate noncontiguous peripheral nerves either simultaneously or sequentially.  Sometimes, mononeuropathy may aggregate resembling polyneuropathy.  Occurs most commonly due to ◦ leprosy and ◦ systemic vasculitis (polyarteritis nodosa, Churg- Strauss syndrome, rheumatoid arthritis, Sjogren's syndrome)
  • 22.  Most common variety of neuropathy.  The nerve fibers are affected in a length- dependent pattern.  A majority of these cases occur due to ◦metabolic, ◦toxic or ◦systemic disorders.
  • 23.  In a polyneuropathy, manifestations can be classified as ◦ Small-fiber sensory, ◦ Large-fiber sensory, ◦ Motor ◦ Autonomic
  • 25.  Clinical evaluation is often helpful in categorizing a neuropathy as ◦ axonal, ◦ demyelinating, ◦ neuronal [dorsal root ganglion (DRG)]  Most axonal neuropathies follow length-dependent pattern with sensory symptoms & signs predominating over motor; distal reflexes are absent.
  • 26. Most demyelinating neuropathies affect motor & sensory fibers (large fiber > small fiber) equally & areflexia or hyporeflexia is more generalized. DRG lesions involve purely sensory fibers in a non-length-dependent fashion; sensory ataxia & generalized loss of reflexes are usually found.
  • 28.  The is important in categorizing neuropathy. ◦ Acute (<4 weeks), ◦ Sub-acute (4–8 weeks) ◦ Chronic (>8 weeks).
  • 30.  The standard history, physical examination and well planned battery of investigations serve as general framework to determine the etiology of neuropathy  Despite of this, in 25 to 30% of the patients in tertiary referral centers evaluated by experts, the etiology cannot be established.
  • 31.  History should include questions regarding ◦ occupation (possibility of toxic exposures to solvents, glues, fertilizers) ◦ dietary habits (e.g. strict vegan diet) ◦ excessive alcohol intake, ◦ smoking (para-neoplastic disease). ◦ sexual history (HIV, hepatitis C)  A childhood history of ‘‘clumsiness’’ or poor athletic performance suggests a hereditary cause
  • 32.  History should focus on illnesses associated with neuropathy, such as ◦ endocrinopathy (diabetes mellitus, hypothyroidism), ◦ renal insufficiency, ◦ hepatic dysfunction, ◦ connective tissue disorders, ◦ Cancer  Surgical history should address ◦ bariatric surgery, ◦ multiple orthopedic procedures, ◦ surgeries for ‘‘entrapped nerves.’’
  • 33.  Skin and mucous membranes may demonstrate ◦ Maculo-anesthetic patches with thickened nerves (Leprosy) ◦ purpura, livedo reticularis (vasculitis ) ◦ oral ulcers ( HIV), ◦ salivary gland swelling, dry eyes or mouth (sarcoidosis, Sjogren syndrome), ◦ gum ‘‘lead lines’’ (lead exposure).
  • 34.  Nerve enlargement can be seen in ◦ Leprosy ◦ Heriditary motor and sensory neuropathy ◦ Refsum’s disease ◦ Amyloidosis  Easy locations to palpate nerves are ◦ the greater auricular nerve ◦ the ulnar nerve ◦ the superficial radial nerve ◦ the common peroneal nerve
  • 35.  Skeletal deformities hammer toes, pes cavus, and kyphoscoliosis are suggestive of an inherited polyneuropathy.  Feet should be specifically examined for signs of trauma as an insensate foot could be an early indicator of an impending Charcot foot deformity.
  • 36.  Anosmia (Refsum's disease, vitamin B12 deficiency)  Optic atrophy (inherited neuropathies,vit B12 deficiency)  External ophthalmoplegia (Miller Fisher syndrome, Botulism,Diabetes)  Trigeminal sensory loss (Sjogren's syndrome)  Facial weakness (GB syndrome)
  • 37.  Muscle power testing in context of nerve & root distribution is crucial.  It should assess muscle bulk, tone, and strength.  Because most neuropathies cause distal weakness, the intrinsic foot muscles may be affected first, resulting in clawed feet and hammer toes.
  • 38.  Approached with nerve anatomy & disease type in mind.  Monofilament probes can grade severity of loss.  Test modalities that sub-serve ◦ large fibers (vibration, joint position and Rhomberg’s test) ◦ small fiber (pinprick, pain and temperature)
  • 39.  Ankle hyporeflexia or areflexia is common in large fiber neuropathy,  Ankle reflexes are typically preserved with small fiber neuropathy (SFN). .  Distal reflex loss are characteristic of length-dependent axonopathies.
  • 41.  Routine blood investigations: ◦ Blood count ◦ ESR ◦ Blood sugar ◦ Liver and renal function tests ◦ Serum vitamin B12 ◦ Thyroid function test  Blood investigations depending upon suspected etiology ◦ Vasculitis profile ◦ HIV ELISA ◦ Heavy metal screening
  • 42.  Electrodiagnostic studies ◦ EDx studies may be repeated to monitor disease progression. ◦ These tests are the standard for large fiber polyneuropathy diagnosis and are normal in purely SFN.
  • 43.  Bedside autonomic tests: ◦ Blood pressure response to standing (Normal fall: <20/10 mmHg), ◦ HR variation with respiration (normal: ≥15 beats/m, I:E ratio 1.2),
  • 44.  Cerebrospinal fluid (CSF) ◦ useful in CIDP, AIDP and chronic immune-mediated axonal neuropathies where CSF protein are elevated Genetic testing – For hereditary causes
  • 45.  Rarely performed now a days  Primary indication is amyloid neuropathy and vasculitis  Should only be performed when NCS is abnormal  Sural nerve is the most commonly biopsied nerve as it is pure sensory nerve
  • 46.  Sometimes used to diagnose small fibre neuropathy  Used to measure density of small unmyelinated fibre  Density of these fibres are reduced in whom nerve biopsy and NCS are abnormal
  • 47.  Other tests ◦ chest x-ray or CT-thorax for sarcoidosis; ◦ PET scan or CT of chest, abdomen, and pelvis for malignancy; ◦ Skeletal survey and bone marrow biopsy for lymphoproliferative diseases ◦ Salivary gland biopsy for Sjogren syndrome; ◦ Endoscopy and duodenal biopsy for celiac disease ◦ MRI may document nerve root enhancement in CIDP, show nerve root clumping in arachnoiditis, or reveal nerve enlargement in tumors.
  • 49. Diabetes1 2 Paraproteinaemia2 3 Alcohol misuse1 Renal failure1 Vitamin B-12 deficiency1 HIV infection1 Chronic idiopathic 4 axonal neuropathy Prevalence 11-41% (depending on duration, type,and control) 9-10% 7% 4% 3.6% 16% (depending on the population studied, usually much lower) 10-40% of different hospital series BMJ 2010:341:c6100
  • 50. SJOGREN’S SYNDROME VIT B12 NEUROPATHY CISPLATIN PYRIDOXINE NEUROTOXICITY FRIEDEREICH’S ATAXIA
  • 51. Heriditary sensory neuropathy Lepromatous leprosy Diabetes mellitus Amyloidosis(early familial&primary) Tangier disease Fabry’s disease-pain predomonates Dysautonomia-riley-day syndrome HIV & antiretroviral therapy neuropathy
  • 52. Global sensory loss Carcinomatous sensory neuropathy Hereditary sensory neuropathy Diabetic sensory neuropathy Vacor intoxication Xanthomatous neuropathy of primary biliary cirrhosis
  • 53. Immune neuropathies Heriditary motor sensory neuropathies Acute intermittent porphyria Diphtheritic neuropathy Lead neuropathy Brachial neuritis Diabetic lumbosacralplexus neuropathy
  • 55. RECURRENT POLYNEUROPATHY Relapsing CIDP Porphyria Refsum’s disease HNPP GBS Beriberi Toxic neuropathy
  • 56. ◦ Guillain-Barré syndrome ◦ Chronic inflammatory demyelinating polyradiculoneuropathy ◦ Diabetes mellitus ◦ Porphyria ◦ Osteosclerotic myeloma ◦ Waldenstrom's macroglobulinemia ◦ Monoclonal gammopathy of undetermined significance ◦ Acute arsenic polyneuropathy ◦ Lymphoma ◦ Diphtheria ◦ HIV/AIDS ◦ Lyme disease ◦ Hypothyroidism ◦ Vincristine (Oncovin, Vincosar PFS) toxicity
  • 57.  Treatment of the underlying disorder ◦ Glycemic control for diabetic neuropathy, ◦ Vitamin replacement for B12 deficiency, ◦ Immunosuppression for vasculitis, ◦ Surgery for entrapment neuropathy, ◦ Enzyme replacement for genetic diseases  Pain management  Supportive care to protect and rehabilitate damaged tissue.
  • 58.  First line-Lidoderm 5% patch,TCA,Gabapentin Pregabalin,Duloxetine  Second line- Carbamazepine,Phenytoin,Venlafaxine,Trama dol  Third line-Mexiletene  Others-EMLA Cream,Capsaicin
  • 60. case of neuropathy | Motor Sensory Autonomic Mixed | Focal Multifocal Generalized | Proximal or Distal Symmetric or asymmetr | UMN features present or not | Acute Subacute Chronic | Narrow down etiology and go for Edx studies